US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
pharma · Pulmonary Arterial Hypertension (PAH)
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals GmbH
AOP Orphan Pharmaceuticals drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Wien, AT HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Wien, AT
- Programs
- 2
- Drugs
- 1
- Patents
- 7
AOP Orphan Pharmaceuticals pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
AOP Orphan Pharmaceuticals drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.